American Healthcare REIT, Inc. (AHR) has amended and extended its 2026 credit facility, through its operating partnership, executing a second amendment to its existing 2024 credit agreement. This update extends the maturity of revolving loans to April 1, 2030, sets current borrowing capacity at $1.35 billion, and maintains term loans maturing January 19, 2027. Analysts currently rate AHR as a Buy with a $55.00 price target, while TipRanks’ AI Analyst, Spark, rates it Neutral due to strong financial trajectory and earnings momentum offset by valuation risk.
American Healthcare REIT (NYSE: AHR) announced it will release its first quarter 2026 earnings on May 7, 2026, after market close, followed by a public conference call and webcast on May 8, 2026, at 10:00 a.m. PT / 1:00 p.m. ET. The company will review its Q1 2026 results, discuss recent events, and conduct a Q&A session. Investors can access the webcast or join via telephone, with a digital replay and full earnings report available on the company's Investor Relations website shortly after the call.
Aberdeen Group plc significantly increased its stake in American Healthcare REIT (AHR) by 24.5%, now holding shares worth $63.01 million. This increase comes as AHR missed its quarterly earnings and revenue consensus, despite an 11.3% year-over-year revenue growth and a declared quarterly dividend. The company's dividend payout ratio is currently elevated at 243.9%, indicating that dividend payments exceed current earnings, while institutional investors own about 16.68% of the stock.
